C. R. Bard

Health medical devices medtech surgical solutions

C. R. Bard, Inc. is a multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology, and surgical specialties. The Company markets its products and services worldwide to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities.

Revenue(FY, 2016)

$3.7 B

Market capitalization(2017-12-22)

$24.4 B

Type

Public

New Providence, US

Founded

1907

Size (employees)

16,300 (est)

Website

crbard.com

C. R. Bard was founded in 1907 and is headquartered in New Providence, US

Report incorrect company information

C. R. Bard Office Locations

C. R. Bard has offices in Stuart, New Providence, Salt Lake City, Covington and in 2 other locations

New Providence, US (HQ)

730 Central Ave

Covington, US

8195 Industrial Blvd

New Providence, US

111 Spring Ridge Dr

Salt Lake City, US

605 N 5600 W

Stuart, US

2979 SE Gran Park Way

Tempe, US

1415 W 3rd St

Show all (7)

Report incorrect company information

C. R. Bard Financials and Metrics

C. R. Bard Financials

C. R. Bard's revenue was reported to be $3.71 b in FY, 2016 which is a 8.7% increase from the previous period.

Summary

USD
Revenue (Q3, 2017)	989.8 m
Gross profit (Q3, 2017)	610.6 m
Gross profit margin (Q3, 2017), %	61.7%
Net income (Q3, 2017)	94.1 m
Market capitalization (22-Dec-2017)	24.4 b
Cash (30-Sep-2017)	1.2 b
EV	24.4 b

C. R. Bard's current market capitalization is $24.4 b.

Income Statement

Annual

USD	FY, 2015	FY, 2016
Revenue	3.4 b	3.7 b
Revenue growth, %	3%	9%
Cost of goods sold	1.3 b	1.4 b
Gross profit	2.1 b	2.3 b

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017
Revenue	758 m	799.3 m	827.1 m	830 m	819.7 m	859.8 m	865.7 m	873.5 m	931.5 m	941.9 m	938.8 m	979.7 m	989.8 m
Cost of goods sold	291.9 m	309.5 m	320.7 m	308.9 m	311.2 m	333.7 m	336.3 m	320.4 m	351 m	352.2 m	354.2 m	361.3 m	379.2 m
Gross profit	466.1 m	489.8 m	506.4 m	521.1 m	508.5 m	526.1 m	529.4 m	553.1 m	580.5 m	589.7 m	584.6 m	618.4 m	610.6 m
Gross profit Margin, %	61%	61%	61%	63%	62%	61%	61%	63%	62%	63%	62%	63%	62%

show all

Balance Sheet

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Cash	1.1 b	960.1 m	950.5 m	905 m
Inventories	356.2 m	376.2 m	413.7 m	483 m
Current Assets	2.1 b	2 b	2.1 b	2.3 b

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017
Cash	781.7 m	939.9 m	996.1 m	971.7 m	1 b	1.1 b	1 b	765 m	797.8 m	996.4 m	890.7 m	976.5 m	1.2 b
Inventories	332.1 m	364.2 m	374.3 m	379.9 m	377.8 m	383.6 m	381.1 m	439.7 m	470.5 m	487.7 m	497.2 m	514.8 m	529.3 m
Current Assets	1.8 b	1.9 b	2 b	2 b	2 b	2.2 b	2.1 b	2.1 b	2.2 b	2.3 b	2.3 b	2.4 b	2.6 b
Goodwill	971 m	1.1 b	1.1 b	1.1 b	1.1 b	1.1 b	1.1 b	1.3 b	1.3 b	1.3 b	1.3 b	1.3 b	1.3 b

show all

Cash Flow

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Net Income	689.8 m	294.5 m	135.4 m	531.4 m
Depreciation and Amortization	146.4 m	174.1 m	193.1 m	213.4 m
Inventories	(36 m)	(54 m)	(33 m)	(83.7 m)
Accounts Payable	(77.3 m)	(35 m)	(217.3 m)	(318.8 m)

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017
Net Income	93.2 m	148.4 m	(119.4 m)	131.3 m	139.8 m	(54.7 m)	(86 m)	116.2 m	159.2 m	96.4 m	178.1 m
Inventories						383.6 m	381.1 m	439.7 m	470.5 m	487.7 m	497.2 m
Accounts Payable						69.9 m	73.3 m	96.8 m	91.5 m	95.7 m	102 m